Pharmalive - The Pulse of the Pharmaceutical Industry


Search Criteria: Search In:  
Special Reports Conferences

Browse Categories
Biotech Companies
Brands
Drug Delivery
DTC Advertising
Healthcare Agencies
Japanese Pharma Companies
Life Sciences Investment
Medical Device Companies
New Drugs
Personnel and Leadership
Pharma Companies
Pipelines
Specialty Pharma Companies
Therapeutic Categories

Featured Report

Price: $570.00
Published: 07/2010
Format: PDF
Total pages: 237

Report Combo: Top 100 Medical Device Companies and New Medical Device Review and Outlook

Introductory rate of $570 expires 8/18/10. Save $150 off the regular rate of $720. Click the sample link below to view the complete table of contents and select pages.

Breakthrough advancements in medical devices and convergent technologies for the development of next-generation products have improved patient monitoring, safety and outcomes, reduced recovery time, and prevented costly complications.

Many U.S.-based medical device and technology companies are developing partnerships on a global scale to pursue innovation and implement strategies that will allow them to expand into emerging markets. Corporate managers believe that this strategy will offset the impact of diminishing VC investment due to almost-certain changes regarding the U.S. approval pathway for medical devices and the proposed innovation tax that skeptics fear may stifle innovation, decrease job opportunities, and limit solutions available to patients.

This publication features the world’s leading medical device and technology companies. This report provides an authoritative and complete overview of the largest manufacturers of medical devices and technologies around the globe in a convenient and concise format. Included are rankings of the largest device companies based on 2009 revenue and a corporate profile of each entity.

Company data featured in this edition include:
• Company overview
• Financials for recent years
• Rankings by revenue
• Leadership personnel
• Recent acquisitions
• Significant subsidiaries
• Medical specialties/sectors
• Key products

Medical devices that would have been considered science fiction just a few years ago are quickly becoming the standard of care. Over the next few years, advances in medical device technology will revolutionize the way treatments are administered.

Popular trends in medical device innovation include combination devices of drugs and biologics, nanotechnology, use of less-invasive surgeries and devices, and IT/wireless technology for hospitals. In the next few years, neurology, cardiovascular and orthopedics represent promising technological opportunities due to an aging population. Industry segments such as oncology and cardiology remain more immune to market dynamics and changes.

Many medical device companies expect that healthcare legislation could have a negative impact on the industry during 2010. The largest challenge will be an increase in FDA regulations for oversight as well as compliance. However, this legislation will not stop the industry from generating solid revenue growth.

This special report about medical device approvals includes the following information:

– A recap and analysis of the promising and anticipated medical devices approved by the U.S. Food and Drug Administration via the Premarket Approval (PMA) process during 2009 and early 2010.

– A complete listing of the medical devices cleared for marketing by FDA via the 510(k) Premarket Notification process in 2009, including the following details for each entry:
• Product code
• Product description
• Registration number
• Company
• Decision date


view sample | View TOC | add to cart


Search for a Report

Build Reports On Demand
PharmaLive OnDemand Special Reports allow users to generate custom reports by selecting only the data they need. The report cost is based on the amount of data selected.

Choose a starting point below and click "Create Report". As you move through the selection process, you will be able to create additional filters.

Company Report
Disease/Medical Usage Report
Therapeutic Category Report
Phase of Development Report

Biotech Companies View All
Biotech/Biopharma/Biosimilar Review and Outlook 2010

Mergers & Acquisitions, Partnerships, & Collaborations 2010 - Review and Outlook


Brands View All
Diabetes Review and Outlook 2010

Top 500 Prescription Medicines 2009


Drug Delivery View All
Drug Delivery Review and Outlook 2010


DTC Advertising View All
Direct-to-Consumer Advertising: Review and Outlook 2010

Report Combo: New Drugs Outlook, Direct-to-Consumer, and Advertising Account Rosters: Healthcare Marketing Communications Agencies


Healthcare Agencies View All
Account Rosters: Healthcare Marketing Communications Agencies 2010

Report Combo: New Drugs Outlook, Direct-to-Consumer, and Advertising Account Rosters: Healthcare Marketing Communications Agencies


Japanese Pharma Companies View All
Top 20 Japanese Companies and Their Pipelines 2009

Top Company Combination: Top 50 Pharma, Top 50 Biotech, Top 50 Specialty Companies, and Top 15 Japanese Pharma Companies


Life Sciences Investment View All
Biotech/Biopharma/Biosimilar Review and Outlook 2010

Global Bioscience Private Venture Investment Review: 2Q09 & 1H09 Trend Analysis


Medical Device Companies View All
Report Combo: Top 100 Medical Device Companies and New Medical Device Review and Outlook

Top 100 Medical Device Companies 2010


New Drugs View All
Combo Report: New Drug & Device Review and Outlook

Diabetes Review and Outlook 2010


Personnel and Leadership View All
People on the Move: First-Quarter 2010

People on the Move: First, Second, Third, and Fourth Quarter 2009


Pharma Companies View All
Drug Delivery Review and Outlook 2010

Biotech/Biopharma/Biosimilar Review and Outlook 2010


Pipelines View All
Drugs in Development: From Pipeline to Market 2010

Diabetes Review and Outlook 2010


Specialty Pharma Companies View All
Drug Delivery Review and Outlook 2010

Mergers & Acquisitions, Partnerships, & Collaborations 2010 - Review and Outlook


Therapeutic Categories View All
Oncology Review and Outlook 2010

Diabetes Review and Outlook 2010




©2010 Canon Communications Pharmaceutical Media Group